Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer - Takeaways - MDSpire

Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer

  • By

  • Hongxia Wang

  • Yijie Li

  • Zhifen Yang

  • Jinxiu Wang

  • Kaiyun Qin

  • Yu Yu

  • Na Wang

  • Jingde Jia

  • Wenhong Zhao

  • Fenghua Zhang

  • Mario M. Leitao

  • Ran Meng

  • Yueping Liu

  • Yan Ding

  • Zhengmao Zhang

  • June 15, 2026

  • 0 min

Share

  • 1

    A retrospective study analyzed 255 patients with advanced epithelial ovarian cancer and intestinal metastases from 2015 to 2020.

  • 2

    The bowel resection group had a 75.4% R0 rate and higher surgical complexity scores compared to the bowel tumor stripping group.

  • 3

    Intraoperative complications were significantly lower in the bowel tumor stripping group, with a 0% anastomotic fistula rate.

  • 4

    Five-year overall survival and progression-free survival rates were similar between the two surgical groups after achieving R0.

  • 5

    Bowel tumor stripping does not negatively impact prognosis if R0 cytoreductive surgery is achieved, and excessive bowel resection does not improve survival.

Original Source(s)

Surgical treatment and prognosis in patients with intestinal metastases originated from advanced epithelial ovarian cancer

  • by Hongxia Wang, Yijie Li, Zhifen Yang, Jinxiu Wang, Kaiyun Qin, Yu Yu, Na Wang, Jingde Jia, Wenhong Zhao, Fenghua Zhang, Mario M. Leitao, Ran Meng, Yueping Liu, Yan Ding, Zhengmao Zhang

  • June 15, 2026

Related Content

Autophagy modulation in gynaecologic oncology: insights into immune regulation and therapeutic potential

Editorial: Cancer Immunosurveillance

Imaging features and differentiation between benign and malignant Brenner tumors in a multi-center cohort